Show simple item record

Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells

dc.contributor.authorGarcia Borja, Elena
dc.contributor.authorSiegl, Frantisek
dc.contributor.authorMateu Sanz, Rosana
dc.contributor.authorSlaby, Ondrej
dc.contributor.authorŠedo, Aleksi
dc.contributor.authorBušek, Petr
dc.contributor.authorSana, Jiri
dc.date.accessioned2024-02-07T14:40:38Z
dc.date.available2024-02-07T14:40:38Z
dc.date.issued2024
dc.identifier.urihttps://hdl.handle.net/20.500.14178/2240
dc.description.abstractSmall noncoding RNAs play an important role in various disease states, including cancer. PIWI proteins, a subfamily of Argonaute proteins, and PIWI-interacting RNAs (piRNAs) were originally described as germline-specific molecules that inhibit the deleterious activity of transposable elements. However, several studies have suggested a role for the piRNA-PIWI axis in somatic cells, including somatic stem cells. Dysregulated expression of piRNAs and PIWI proteins in human tumors implies that, analogously to their roles in undifferentiated cells under physiological conditions, these molecules may be important for cancer stem cells and thus contribute to cancer progression. We provide an overview of piRNA biogenesis and critically review the evidence for the role of piRNA-PIWI axis in cancer stem cells. In addition, we examine the potential of piRNAs and PIWI proteins to become biomarkers in cancer.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1186/s40364-024-00563-3
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titleCritical appraisal of the piRNA-PIWI axis in cancer and cancer stem cellsen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2024-03-21T13:10:42Z
dc.subject.keywordCanceren
dc.subject.keywordCancer stem cellsen
dc.subject.keywordPIWI proteinsen
dc.subject.keywordPIWI-interacting RNAsen
dc.subject.keywordpiRNAsen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/SVV/SVV260519
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/LM/LM2015064
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/EF/EF16_019/0000785
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/OP VVV/CZ.02.1.01/0.0/0.0/16_019/0000785
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MZ0/NV/NV19-03-00501
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5102
dc.date.embargoStartDate2024-03-21
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1186/s40364-024-00563-3
dc.identifier.utWos001155019100001
dc.identifier.eidScopus2-s2.0-85183690921
dc.identifier.obd643495
dc.identifier.pubmed38303021
dc.subject.rivPrimary30000::30200::30204
dcterms.isPartOf.nameBiomarker Research
dcterms.isPartOf.issn2050-7771
dcterms.isPartOf.journalYear2024
dcterms.isPartOf.journalVolume12
dcterms.isPartOf.journalIssue1
uk.faculty.primaryId108
uk.faculty.primaryName1. lékařská fakultacs
uk.faculty.primaryNameFirst Faculty of Medicineen
uk.department.primaryId1492
uk.department.primaryNameÚstav biochemie a experimentální onkologie 1. LF UKcs
uk.department.primaryNameInstitute of Biochemistry and Experimental Oncologyen
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitleCritical appraisal of the piRNA-PIWI axis in cancer and cancer stem cellsen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record